Drug Testing Locations - Chattanooga, TN

Drug Testing in Chattanooga, TN

Chattanooga, Tennessee Statistics

Chattanooga, located in Hamilton County, has reported an increase in opioid-related overdoses over the past few years.

In 2020, Hamilton County witnessed over 140 overdose deaths, with opioids being a major contributor.

Chattanooga emergency rooms see a high volume of drug-related visits, with heroin and methamphetamines prevalent.

The Tennessee Department of Health noted that Hamilton County's naloxone administration rates are among the highest in the state.

Chattanooga's addiction treatment centers have seen a rise in admissions, particularly for opioid addiction.

Drug-related crime in Hamilton County has remained a significant challenge for local law enforcement.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Chattanooga, TN & Drug Testing Policies

Employers in Chattanooga, TN recognize the impact of drug use on workplace productivity and safety, which is why many have implemented strict drug testing policies. These policies often involve pre-employment screening and random drug testing practices.

For further guidance on establishing these policies, local businesses can consult the U.S. Department of Labor resources to ensure they comply with federal regulations while promoting a drug-free workplace environment.

Government Efforts with Drug Problems in Chattanooga, TN

The government of Chattanooga, TN is actively working to combat drug abuse through initiatives aimed at prevention, treatment, and enforcement. Local authorities have partnered with organizations like the Tennessee Department of Mental Health and Substance Abuse Services to provide increased access to treatment programs.

Efforts also include collaboration with the Drug Enforcement Administration to enhance enforcement against drug trafficking and distribution networks within Hamilton County. These multifaceted approaches are aimed at addressing both the supply and demand aspects of the drug problem.

Local Drug Busts & News in Chattanooga, TN

Chattanooga has been the site of several high-profile drug busts as local law enforcement intensifies efforts to curb drug distribution. Recently, coordinated raids led to the seizure of significant quantities of heroin and methamphetamine, disrupting major supply chains.

These events highlight ongoing enforcement activities aimed at dismantling drug networks around Hamilton County. Local media frequently reports on such efforts, keeping residents informed about the progress and challenges in the fight against drug trafficking.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Chattanooga, TN. Trusted by employers nationwide for accurate results and exceptional service.

Tennessee DOT/Non DOT Physicals

Tennessee Vision Tests

Tennessee Audiograms

Tennessee Respirator Fit Tests

Tennessee Lift Tests

Tennessee Background Checks

Clinical Testing Services

TB Testing in TN

Diabetes Testing in TN

Infectious Disease Testing in TN

Sickle Cell Anemia Testing in TN

Women/Men's Health Testing in TN

Resources & Citations

Tennessee Department of Mental Health and Substance Abuse Services

Chattanooga CARES

Tennessee Suicide Prevention Network

Hamilton Flourishing

Tennessee Association of Alcohol, Drug & other Addiction Services

Nar-Anon Family Groups Tennessee

Oxford House Tennessee

ARCH - Addiction Recovery Care in Tennessee

Partnership for Families, Children, and Adults

Drug Testing Near Chattanooga, TN

Hixson, TN

Whiteside, TN

East Brainerd, TN

Falling Water, TN

Harrison, TN

Fairmount, TN

Signal Mountain, TN

Shepherd, TN

Red Bank, TN

Lookout Mountain, TN

East Ridge, TN

Ridgeside, TN

Frequently Asked Questions

Customer Reviews